<?xml version="1.0" encoding="UTF-8"?>
<p>Although the world is already preparing to tackle the newest emergent virus strain [
 <xref rid="B1-healthcare-08-00204" ref-type="bibr">1</xref>], vaccine research and development are highly complex and require concerted public funding efforts for a long period of time [
 <xref rid="B8-healthcare-08-00204" ref-type="bibr">8</xref>,
 <xref rid="B13-healthcare-08-00204" ref-type="bibr">13</xref>]. In order to improve the efficiency of the allocation of the funding for infectious disease-related R&amp;D, it is necessary to understand the current trends of coronavirus disease-related scientific research funding around the world to consider the directions for the global collaborative research and development [
 <xref rid="B14-healthcare-08-00204" ref-type="bibr">14</xref>,
 <xref rid="B15-healthcare-08-00204" ref-type="bibr">15</xref>].
</p>
